Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/2/12 → 11/28/13 |
Funding
- Otsuka America Pharmaceutical Incorporated: $7,500.00
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Four-Arm, Multicenter, Dose-Finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Central Neuropathic Pain
- Coyle, Patricia K (PI)
- Kowalska, Agnieszka (CoPI)
Project: Research